摘要
为探讨地塞米松促胎肺成熟是否同时诱发早产，对１６例妊娠２８～３６周间胎膜早破孕妇用＞１０ｍｇ地塞米松促胎肺成熟者进行了回顾性比较研究。对照组选用同期１６例可比性较好，未行促胎肺成熟处理的胎膜早破孕妇。结果用药组孕妇在用地塞米松处置后的２４－４８小时内，诸早产指标皆低于对照组（Ｐ＞０．０５）．表明地塞米松促胎肺成熟不增加早产的危险性。
In order to know whether or not dexamethasone(DXM) simultaneously induces preterm labor when used for the acceleration of the fetal lung muturation(AFLM), a comparison study was carried out. The subjects were the 32 patients who suffered from preterm rupture of membrane(PROM) and were in the 28-36 gestational weeks. The results show that all of the three preterm labor targets of the study group(16 cases, administered with DXM for AFLM) were not significantly higher than those of the control group(16 cases, not given any medicine for AFLM)(P> 0.05), i.e., AFLM with DXM does not inerease the preterm labor risk.
出处
《南通医学院学报》
1994年第1期77-78,共2页
ACTA Academiae Medicinae Nantong
关键词
胎膜早破
地塞米松
早产
dexamethasone, preterm labor, acceleration of lung maturation, preterm rupture of membrane
